The challenges of delivering pharmacogenomics into clinical pediatrics
Open Access
- 1 March 2002
- journal article
- perspective
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 2 (3) , 141-143
- https://doi.org/10.1038/sj.tpj.6500104
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- PHARMACOGENETICS AND PHARMACOGENOMICSPediatric Clinics of North America, 2001
- Ethical Issues With Genetic Testing in PediatricsPediatrics, 2001
- Integrating genotype and phenotype information: an overview of the PharmGKB projectThe Pharmacogenomics Journal, 2001
- A Viewpoint on Evolutionary Economic TheoryPublished by Springer Nature ,2001
- The environment as an etiologic factor in autism: a new direction for research.Environmental Health Perspectives, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Guidelines for the ethical conduct of medical research involving childrenArchives of Disease in Childhood, 2000
- Reye's Syndrome in the United States from 1981 through 1997New England Journal of Medicine, 1999
- CALENDARCancer Treatment Reviews, 1999
- Valproic acid hepatic fatalities. III. U.S. experience since 1986Neurology, 1996